Journal ·
Stock market week in review, Saturday 21 November 2026
A review of the week in US stocks: where the market regime stands, what moved it and what to watch next week.
Regime Risk-offThe week in review
The settled close-of-day read of 20 November 2026 is risk-off. All three conditions in the regime rules point the same way: the S&P 500 (via SPY) closed −5.7% from its 200-day average, 289 of 999 stocks were above their own 50-day average, and the VIX closed at 35.89.
The read is unchanged from the previous close-of-day read. Breadth is deteriorating, and the VIX sits in its stressed band, above 28. The VIX measures the S&P 500's expected swings over the next 30 days, as priced in options.
Credit made the week's largest move outside stocks. The high-yield spread, the extra yield investors demand on lower-rated corporate bonds over Treasuries, widened 32 basis points (bp) week over week to 3.52% as of 19 November 2026, according to Federal Reserve data. Treasury yields fell over the same week. The 10-year yield was 5.04% on 19 November 2026, down 6 bp week over week. The 2-year was 4.76%, down 10 bp.
The fall in the 10-year yield came through inflation expectations. The 10-year breakeven inflation rate dropped 9 bp to 2.15% as of 20 November 2026, while the real 10-year rate rose 2 bp to 2.88%. Wider credit spreads alongside falling Treasury yields fit a market paying for safety.
Labor figures show no matching strain. Initial jobless claims were 203K in the week ending 14 November 2026, up 1K week over week. Unemployment was 4.1% in October 2026, and nonfarm payrolls stood at 159.3M. Housing starts ran at 1,309K in October. The effective fed funds rate was 3.88% on 19 November 2026.
These rate, credit, labor and housing figures are context for the reading. Under the regime rules, only the S&P 500's distance from its 200-day average, breadth and the VIX move the call.
The call leaves risk-off only when three things hold together: the S&P 500 is back within 2% of its 200-day average, breadth is back at 40% or above, and the VIX is back at 28 or below. The call would then read neutral unless the risk-on conditions are also met. Those are the S&P 500 more than 0.5% above its 200-day average (now −5.7%), breadth above 60% (now 28.9%) and the VIX below 28 (now 35.89).
| Measure | Level | As of | Week over week | Read |
|---|---|---|---|---|
| Regime | Risk-off | 2026-11-20 | — | Close-of-day read |
| S&P 500 vs its 200-day average | −5.7% | 2026-11-20 | — | More than 2% below |
| Stocks above their own 50-day average | 28.9% (289 of 999) | 2026-11-20 | — | Deteriorating; under 40% |
| VIX | 35.89 | 2026-11-20 | — | Stressed; above 28 |
| 10-year Treasury yield | 5.04% | 2026-11-19 | −6 bp | Context |
| 2-year Treasury yield | 4.76% | 2026-11-19 | −10 bp | Context |
| 10-year minus 2-year spread | 0.29% | 2026-11-20 | +2 bp | Context |
| 10-year breakeven inflation | 2.15% | 2026-11-20 | −9 bp | Context |
| Real 10-year rate | 2.88% | 2026-11-19 | +2 bp | Context |
| High-yield credit spread | 3.52% | 2026-11-19 | +32 bp | Context |
| Effective fed funds rate | 3.88% | 2026-11-19 | — | Context |
| Initial jobless claims | 203K | Week ending 14 November 2026 | +1K | Context |
| Unemployment rate | 4.1% | October 2026 | — | Context |
| Nonfarm payrolls | 159.3M | October 2026 | — | Context |
| Housing starts | 1,309K | October 2026 | — | Context |
Themes in motion
Ten themes were given a stage in the theme run on the 20 November 2026 close: 2 accelerating, 5 maturing, 3 saturated.
Oncology & immunology and heavily shorted stocks are accelerating. Buying is spreading across each group, and the news behind them is fresh.
Five themes are maturing: ad tech & digital advertising; medtech, diagnostics & life-science tools; rare disease & gene therapy; cyclical industrials; and travel & leisure. Their stories are widely known and the stocks are still holding up, but the news flow has turned repetitive.
AI enterprise software, consumer brands & retail, and fintech, payments & credit are saturated. Their stories are largely reflected in the price already, and few new buyers remain.
Rated highest this week
Two research notes are rated high conviction: Advantest Corporation (ATEYY) and Azenta, Inc. (AZTA).
- Advantest Corporation (ATEYY). The research expects the chip-tester supplier to outperform the S&P 500 over the next three months. The case rests on rising customer volumes and on the company's ¥967.0 billion operating income forecast, which still stands.
- Azenta, Inc. (AZTA). The research expects Azenta to beat the S&P 500 over the next three months. The basis is the fiscal 2027 plan the company issued on 10 November 2026, which adds 3% to 5% organic growth and a wider margin.
Neither note has yet published a kill line, the condition that would prove its thesis wrong. Both theses are relative calls: each is judged against the S&P 500, not on absolute gains in a risk-off market.
The week ahead
Next week's dated catalysts fall on Sunday, 22 November 2026, and Monday, 23 November 2026. The heaviest are two FDA decisions and Hewlett Packard Enterprise's fiscal fourth-quarter earnings call. Dates marked "estimated" are the research's own estimates, not announced dates.
Sunday, 22 November 2026
- Capricor Therapeutics (CAPR) and CryoPort (CYRX): The FDA action date falls for Capricor's deramiocel biologics license application in Duchenne muscular dystrophy. The application was narrowed to upper-limb impairment. An approval confirms that the narrowed filing was enough. A rejection or a missed date removes the event both stocks are tied to.
- Savara (SVRA): The FDA action date falls for the Molbreevi biologics license application in autoimmune pulmonary alveolar proteinosis. The decision resolves whether Molbreevi reaches the market in this indication. Together with Capricor's, it gives the rare disease & gene therapy theme fresh news.
- Braskem (BAK): The 90-day window to win majority support in each affected creditor class closes. The result shows whether every class has backed the plan.
- Kohl's (KSS): The Black Friday Week event begins and runs to 28 November 2026, followed by Cyber Deals on 29 November 2026 and 30 November 2026. It opens the season's first direct test of shopper demand at Kohl's, which bears on the consumer brands & retail story.
- AMC Entertainment (AMC), estimated date: Opening-weekend estimates arrive for Lionsgate's The Hunger Games: Sunrise on the Reaping. Strong figures would confirm that a major release can draw audiences into theaters; weak ones would undercut that case.
- Yext (YEXT), estimated date: The company is expected to announce the date of its third-quarter fiscal 2027 results; this is unconfirmed. The event settles the timing only.
Monday, 23 November 2026
- Hewlett Packard Enterprise (HPE): The fiscal fourth-quarter 2026 earnings call takes place, as listed on HPE's investor relations site. The results and outlook settle how the company closed its fiscal year.
- Home Depot (HD): Richard McPhail takes office as chief executive, which completes the leadership change.
- Petrobras (PBR): Petrobras presents its 2027–2031 strategic plan. The plan sets the company's priorities for the next five years.
- Nexa Resources (NEXA): Boliden holds an extraordinary general meeting at 10:00 CET in Stockholm on the share issue to Votorantim. The vote decides whether the issue goes ahead.
- Onfolio Holdings (ONFO): Nasdaq's deadline falls for the company to show $2.5 million of stockholders' equity. Meeting it confirms compliance with that requirement. Missing it leaves the Nasdaq listing at risk.
- Bending Spoons (BSP), estimated date: The first trading session after the IPO lock-up ends follows the company's 19 November 2026 results release. That session shows how the stock trades once early holders are free to sell.
- Amazon (AMZN), estimated date: An Ariane 6 launch of Amazon Leo satellites from French Guiana is targeted no earlier than this date. A launch on schedule confirms the deployment timetable; a slip pushes it back.
- Estée Lauder (EL), estimated date: A Form 8-K is expected to report the vote results of the 17 November 2026 annual meeting, which settles how shareholders voted.
Next entry: after the close. Follow